Bufa-20,22-dienolide,16-(acetyloxy)-3,14-dihydroxy-, (3b,5b,16b)- cas no:471-95-4
Synonyms: 5b-Bufa-20,22-dienolide, 3b,14,16b-trihydroxy-, 16-acetate (6CI,8CI); 3b,14,16b-Trihydroxy-5b-bufa-20,22-dienolide 16-acetate; Bufotalin; NSC 89596
NameBufa-20,22-dienolide,16-(acetyloxy)-3,14-dihydroxy-, (3b,5b,16b)-
CAS471-95-4
Synonyms5b-Bufa-20,22-dienolide, 3b,14,16b-trihydroxy-, 16-acetate (6CI,8CI); 3b,14,16b-Trihydroxy-5b-bufa-20,22-dienolide 16-acetate; Bufotalin; NSC 89596
Molecular FormulaC26H36 O6
Molecular Weight444.62
AppearanceWhite to off-white solid.
refractive index1.587
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1(a)
Safety
A deadly poison by ingestion, subcutaneous, and intravenous routes. When heated to decomposition it emits acrid and irritating fumes.
RIDADR: 3172
HazardClass: 6.1(a)
PackingGroup: II
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
cat |
LD50 |
intravenous |
136ug/kg (0.136mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 74, Pg. 223, 1942. |
cat |
LD50 |
unreported |
130ug/kg (0.13mg/kg) |
|
Pharmazie in Unserer Zeit. Vol. 13, Pg. 129, 1984. |
dog |
LDLo |
intravenous |
360ug/kg (0.36mg/kg) |
|
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 152, Pg. 571, 1958. |
dog |
LDLo |
oral |
980ug/kg (0.98mg/kg) |
|
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 152, Pg. 571, 1958. |
frog |
LDLo |
unreported |
1200ug/kg (1.2mg/kg) |
|
Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 86, Pg. 138, 1920. |
mouse |
LD50 |
intravenous |
4130ug/kg (4.13mg/kg) |
behavioral: tremor behavioral: convulsions or effect on seizure threshold behavioral: antipsychotic |
Chemical and Pharmaceutical Bulletin. Vol. 24, Pg. 1714, 1976.
|
mouse |
LD50 |
subcutaneous |
400ug/kg (0.4mg/kg) |
|
Clinical Toxicology. Vol. 4, Pg. 331, 1971. |
mouse |
LD50 |
unreported |
1131ug/kg (1.131mg/kg) |
|
Pharmazie in Unserer Zeit. Vol. 13, Pg. 129, 1984. |